Rumela Chakrabarti, Ph.D. (IMAGE)

University of Miami Miller School of Medicine

Rumela Chakrabarti, Ph.D.

Caption

“This triple therapy approach could be a game-changer for patients whose (breast) cancers no longer respond to standard hormone treatments,” said Rumela Chakrabarti, Ph.D., the study’s senior author and co-director of Sylvester’s Surgical Breast Cancer Research Group. “It’s about hitting the cancer from multiple angles at once.”

Credit

Photo by Sylvester Comprehensive Cancer Center

Usage Restrictions

Use with attribution

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.